Tyra Biosciences, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Todd Harris, with a market cap of $2.0B.
Common questions about Tyra Biosciences, Inc.
Tyra Biosciences, Inc. is scheduled to report earnings for Q1 2026 on May 7, 2026.
Tyra Biosciences, Inc. has approximately 38 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.